Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prostate biopsy histopathologic features correlate with a commercial gene expression assay's reclassification of patient NCCN risk category

Published:2020-09-18 Issue:16 Volume:80 Page:1421-1428
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Greenland Nancy Y.¹²^ORCID,Cowan Janet E.³⁴,Chan Emily¹,Carroll Peter R.³⁴,Stohr Bradley A.¹,Simko Jeffry P.¹³⁴

Affiliation:

1. Department of Anatomic Pathology University of California San Francisco California USA

2. Department of Anatomic Pathology San Francisco Veterans Affairs Health Care System San Francisco California USA

3. Department of Urology University of California San Francisco California USA

4. UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California USA

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24072

Reference33 articles.

1. Active surveillance for prostate cancer: patient selection and management;Klotz L;Curr Oncol,2010

2. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options

3. A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer

4. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

5. The clinical utility of the Genomic Prostate Score in men with very low to intermediate risk prostate cancer;Gaffney C;J Urol,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer–Specific Mortality;JCO Precision Oncology;2021-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3